AITechFundingNewsabout 3 hours ago
Qureight raises $20M for AI clinical trials
4 min read
Qureight closed a $20 million Series B round led by Molten Ventures. The Cambridge company builds AI imaging tools for lung and heart clinical trials. Funds will launch an in-house AI imaging lab and expand into asthma, lung cancer, and pulmonary hypertension.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
